Next Article in Journal
Incorporating Immune Cells into Organoid Models: Essential for Studying Human Disease
Previous Article in Journal
Organoids Are Us
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Organoid Models and Next-Generation Sequencing for Bone Marrow and Related Disorders

1
Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland
2
School of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK
3
Novogene Europe, 25 Science Park, Milton, Cambridge CB4 0FW, UK
4
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS9 7JT, UK
*
Author to whom correspondence should be addressed.
These authors contributed equally to the manuscript.
Organoids 2023, 2(3), 123-139; https://doi.org/10.3390/organoids2030010
Submission received: 26 April 2023 / Revised: 23 May 2023 / Accepted: 8 June 2023 / Published: 1 July 2023

Abstract

Challenges to the musculoskeletal system negatively impact the quality of life of people suffering from them, leading to pain, a decline in mobility, genetic alterations, and potential disorders. The bone marrow (BM) forms an integral part of the musculoskeletal system responsible for erythropoiesis and optimal survival of the various immune and stem cells within the BM. However, due to its dynamic and complex three-dimensional (3D) structure, replicating the BM physiologically in traditional two-dimensional (2D) cell culture settings is often challenging, giving rise to the need for 3D in vitro models to better dissect the BM and its regeneration. Several researchers globally have been investigating various approaches to define an appropriate 3D model for their research. Organoids are novel preclinical models that provide a 3D platform for several tissues and have been analysed using next-generation sequencing (NGS) to identify new molecular pathways at the genetic level. The 3D in vitro models and organoids are increasingly considered important platforms for precision medicine. This review outlines the current knowledge of organoid and 3D in vitro models for the BM. We also discuss different types of 3D models which may be more adaptable for the BM. Finally, we critically review the NGS techniques used for such models and the future combination of these techniques.
Keywords: bone marrow; organoids; in vitro; 3D modelling; bone regeneration; genetics; next-generation sequencing bone marrow; organoids; in vitro; 3D modelling; bone regeneration; genetics; next-generation sequencing

Share and Cite

MDPI and ACS Style

Rausch, M.; Iqbal, N.; Pathak, S.; Owston, H.E.; Ganguly, P. Organoid Models and Next-Generation Sequencing for Bone Marrow and Related Disorders. Organoids 2023, 2, 123-139. https://doi.org/10.3390/organoids2030010

AMA Style

Rausch M, Iqbal N, Pathak S, Owston HE, Ganguly P. Organoid Models and Next-Generation Sequencing for Bone Marrow and Related Disorders. Organoids. 2023; 2(3):123-139. https://doi.org/10.3390/organoids2030010

Chicago/Turabian Style

Rausch, Magdalena, Neelam Iqbal, Shelly Pathak, Heather E. Owston, and Payal Ganguly. 2023. "Organoid Models and Next-Generation Sequencing for Bone Marrow and Related Disorders" Organoids 2, no. 3: 123-139. https://doi.org/10.3390/organoids2030010

APA Style

Rausch, M., Iqbal, N., Pathak, S., Owston, H. E., & Ganguly, P. (2023). Organoid Models and Next-Generation Sequencing for Bone Marrow and Related Disorders. Organoids, 2(3), 123-139. https://doi.org/10.3390/organoids2030010

Article Metrics

Back to TopTop